Press release
US Diabetes Devices Market Poised for USD 35.24 Billion Milestone by 2030, Driven by CGM Adoption
The United States diabetes devices market, valued at USD 26.74 billion in 2025, is expected to reach USD 35.24 billion by 2030, growing at a CAGR of 6.17% according to DataM Intelligence. The surge in market size is powered by rising diabetes prevalence, with over 38.4 million Americans living with the condition, and the growing adoption of connected devices for remote-first care models. Linked to an economic burden of USD 413 billion in 2022, the integration of technology-enabled monitoring and insulin delivery systems has become central to policy and healthcare strategies. Continuous glucose monitoring (CGM) systems lead growth, accounting for the highest share in device sales, supported by Medicare coverage expansions and commercial insurance alignment.The Northeast remains the leading region due to superior insurance coverage, higher income levels, and robust adoption of remote monitoring solutions, while homecare settings dominate end-use with significant telehealth integration. Monitoring devices, especially CGMs, continue to drive innovation, supported by ecosystem-based software upgrades to enhance patient engagement.
Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/diabetes-devices-market
Key Highlights from the Report
➤ Continuous glucose monitoring systems projected to grow at 7.82% CAGR through 2030.
➤ Type 2 diabetes patients account for 92.14% of device volume in 2024.
➤ Homecare settings dominate with 67.34% market share in 2024.
➤ Retail pharmacies hold 61.11% share; e-commerce projected to grow at 7.82% CAGR.
➤ Northeast US leads adoption due to advanced insurance and academic trial presence.
➤ Integration of CGM with smartphone ecosystems is boosting patient engagement.
Market Segmentation
By device type, monitoring devices hold a 58.12% market share in 2024, with CGMs expanding faster than the overall market and replacing traditional SMBG strip usage. Patient segmentation shows type 2 users dominating the market, with new algorithm-driven insulin delivery systems enhancing access. In end-user terms, homecare leads market share, driven by telehealth integration and convenience, while hospitals and specialty clinics see growth from electronic health record-linked devices. Distribution channels remain pharmacy-led but show strong e-commerce expansion through subscription-based delivery models.
Regional Insights
The Northeast commands the largest share due to high per-capita incomes, advanced insurance coverage, and value-based care contract adoption. The Midwest follows with strong urban adoption but faces rural healthcare delivery challenges mitigated by telehealth grants. The South, despite the highest diabetes prevalence, lags in premium device penetration, prompting manufacturers to pilot subsidy models to boost uptake in lower-income populations.
Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/diabetes-devices-market
Market Dynamics
Market Drivers
Rising diabetes prevalence, expanded Medicare coverage for CGMs, youth obesity-induced early diagnoses, and smartphone-linked device ecosystems are driving sustained growth and patient engagement.
Market Restraints
High device costs, insurance coverage limitations, sustainability pressures on single-use pens, and stringent regulatory requirements hinder broader adoption, particularly in lower-income and rural areas.
Market Opportunities
Integration of AI-based analytics, expansion into youth-oriented devices, e-commerce-driven distribution innovations, and broader federal support for remote monitoring open new avenues for growth and retention.
Purchase This Exclusive Report at Just USD 4471 Only: https://www.datamintelligence.com/buy-now-page?report=diabetes-devices-market
Reasons to Buy the Report
✔ Comprehensive market size and growth projections to 2030.
✔ Segmentation insights across device type, patient group, and distribution channels.
✔ Detailed regional analysis identifying high-growth areas.
✔ Competitive landscape profiling leading industry players.
✔ Coverage of evolving payer policies and regulatory approvals impacting adoption.
Frequently Asked Questions (FAQs)
◆ How big is the US Diabetes Devices market in 2025?
◆ What is the projected growth rate of the US Diabetes Devices market through 2030?
◆ Who are the key players in the US Diabetes Devices industry?
◆ What is the forecast for continuous glucose monitoring adoption rates?
◆ Which region will dominate US Diabetes Devices market share during the forecast period?
Company Insights
Abbott
Dexcom
Becton Dickinson
Medtronic
F. Hoffmann-La Roche AG
Recent Developments:
December 2024: Dexcom launched a Generative AI platform using Google Cloud's models to deliver real-time lifestyle nudges based on glucose and activity data.
November 2024: Medtronic secured FDA clearance for InPen app enhancements featuring missed meal dose detection, enabling smarter multiple daily injection workflows linked to CGM data.
Conclusion
The US diabetes devices market is entering a transformative phase, driven by technological convergence, payer policy liberalization, and rising chronic disease prevalence. Continuous glucose monitoring systems, integrated with smartphone ecosystems, are reshaping patient engagement and clinical outcomes. With homecare settings leading adoption and new device approvals expanding access, the industry is set for sustained growth to USD 36.24 billion by 2030, positioning the US as a primary launch market for global diabetes technology innovations.
Contact Us
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com
About Us
DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Diabetes Devices Market Poised for USD 35.24 Billion Milestone by 2030, Driven by CGM Adoption here
News-ID: 4220200 • Views: …
More Releases from DataM Intelligence 4Market Research LLP

Antimicrobial Coating Market Forecast 2024-2031: Growth at 11.1% CAGR Driven by …
The Antimicrobial Coating Market is expected to reach at a CAGR of 11.10% during the forecast period 2024-2031.
The Antimicrobial Coating Market focuses on coatings infused with agents that inhibit the growth of bacteria, fungi, and viruses. These coatings are widely used in healthcare, food processing, and construction sectors to enhance hygiene and safety. Rising awareness about infection control and hospital-acquired infections drives demand. Nanotechnology and silver-based compounds are key innovations…

Global Security Analytics Market (2024-2031): AI-Driven Threat Detection, Predic …
The Security Analytics Market is expected to reach growth at a CAGR of 17.10% during the forecast period (2024-2031).
The Security Analytics Market involves technologies and solutions that analyze security data to detect, prevent, and respond to cyber threats. It integrates big data, machine learning, and behavioral analytics to provide real-time insights into potential vulnerabilities. Organizations use these tools to improve threat detection accuracy and reduce incident response times. The market…

Aseptic Liquid Packaging Market Set for Strong Growth Driven by Sustainability a …
According to DataM Intelligence, the Global Aseptic Liquid Packaging Market is projected to grow at a significant CAGR during 2024-2031. Aseptic liquid packaging involves filling commercially sterile products like beverages, pharmaceuticals, and personal care liquids into sterile containers under aseptic conditions and hermetically sealing them to preserve freshness and shelf life without preservatives.
Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/aseptic-liquid-packaging-market?utm_source=OpenPR&utm_campaign=Onkar
Key…

Robotics in Agriculture Market to Reach US$ 84.19 Billion by 2032, Driven by AI, …
According to DataM Intelligence, the Global Robotics in Agriculture Market was valued at US$ 15.78 billion in 2024 and is projected to reach US$ 84.19 billion by 2032, growing at a CAGR of 23.28% during 2025-2032. The market's robust growth is fueled by the increasing adoption of autonomous farming equipment, AI-powered automation, and the growing global focus on sustainable agricultural productivity. Robotics in agriculture is fundamentally transforming traditional farming through…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…